ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,307.01
      -0.27%
      US Tech 100
      18,307.60
      0.41%
      Dow Jones
      39,671.04
      -0.51%
      Brent Oil
      81.395
      -0.17%
      Bitcoin
      69,266.15
      0.24%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Galectin Therapeutics Inc (GALT)

      7. Galectin Therapeutics Inc (GALT) News

      GALT

      Galectin Therapeutics (GALT)

      Galectin Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GALT
      DateTimeSourceHeadlineSymbolCompany
      05/15/20247:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
      05/15/20247:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GALTGalectin Therapeutics Inc
      03/04/202412:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      02/07/20244:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      01/16/202411:23AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      01/02/20248:07AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      12/18/20238:41AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      12/11/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
      12/07/202311:42AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
      12/01/20234:50PMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      12/01/20234:38PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GALTGalectin Therapeutics Inc
      12/01/20238:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      11/15/20235:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
      11/13/20239:21AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:GALTGalectin Therapeutics Inc
      11/13/20238:45AMGlobeNewswire Inc.UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      11/13/20238:00AMGlobeNewswire Inc.Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      11/13/20237:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GALTGalectin Therapeutics Inc
      11/13/20237:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GALTGalectin Therapeutics Inc
      11/03/20238:00AMGlobeNewswire Inc.Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLDNASDAQ:GALTGalectin Therapeutics Inc
      10/31/20234:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GALTGalectin Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GALT

      Your Recent History

      BIT
      S32538
      Societe Generale Effekten
      BIT
      P1ZR28
      NLBNPIT1ZR28 20241220 900
      Delayed Upgrade Clock